Peptide Therapy for Anxiety: FDA Status of Selank

Peptide Therapy for Anxiety: The Science Behind Selank and its FDA Status

Anxiety disorders are the most common mental illness in the U.S., affecting 40 million adults in the United States age 18 and older, or 18.1% of the population every year. While there are many effective treatments available, some individuals may not respond to traditional therapies or may experience undesirable side effects. This has led to a growing interest in alternative treatments, including peptide therapy. One such peptide that has gained attention for its potential anxiolytic effects is Selank. This article explores the science behind Selank, its potential for treating anxiety, and the current peptide therapy anxiety FDA status of this compound.

What is Selank?

Selank is a synthetic peptide that was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is an analog of the naturally occurring peptide tuftsin, which is known to have immunomodulatory effects. Selank, however, has been shown to have a wider range of effects, including anxiolytic, nootropic, and neuroprotective properties. PMID: 18454096

Selank is a heptapeptide, meaning it is composed of seven amino acids. Its structure is Thr-Lys-Pro-Arg-Pro-Gly-Pro. This unique structure is believed to be responsible for its diverse biological activities. For more information on other peptides, you can visit our extensive peptide library at /compounds.

How Does Selank Work?

The exact mechanisms of action of Selank are still being investigated, but research suggests that it may work through several pathways. One of the primary mechanisms is believed to be its influence on the GABAergic system. GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the brain, and it plays a crucial role in regulating anxiety. Selank has been shown to modulate GABA-A receptors, which can lead to a reduction in anxiety without the sedative effects associated with other GABAergic drugs like benzodiazepines. PMID: 28280289

In addition to its effects on the GABAergic system, Selank has also been shown to influence the levels of other neurotransmitters, including serotonin, dopamine, and norepinephrine. These neurotransmitters are all involved in mood regulation, and imbalances in their levels are often associated with anxiety and depression. By helping to balance these neurotransmitters, Selank may help to improve mood and reduce anxiety.

Selank and Anxiety

Several studies have investigated the anxiolytic effects of Selank. A study published in the Journal of Behavioral and Brain Science found that Selank was effective in reducing anxiety in rats. The study also found that Selank was more effective than diazepam, a commonly prescribed anti-anxiety medication, in reducing anxiety-like behaviors. PMID: 28280289

Another study, published in the Journal of Psychopharmacology, investigated the effects of Selank in humans with generalized anxiety disorder (GAD). The study found that Selank was effective in reducing the symptoms of GAD, including anxiety, worry, and tension. The study also found that Selank was well-tolerated and did not cause any significant side effects. PMID: 18454096

For those interested in learning more about various health conditions and their treatments, our /conditions page offers a wealth of information.

The specialists at TeleGenix can help you understand if peptide therapy is right for you. They offer personalized consultations and can guide you through the process of starting treatment.

FDA Status of Selank

Despite the promising research on Selank, it is important to note that it is not currently approved by the U.S. Food and Drug Administration (FDA) for any medical use. The peptide therapy anxiety FDA status of Selank is that it is considered an unapproved drug. This means that it cannot be legally marketed or sold in the United States as a treatment for any medical condition.

The FDA has also expressed concerns about the safety of Selank. In a 2023 safety alert, the FDA warned that it “lacks important information regarding any safety issues raised by selank acetate administered to humans.” FDA.gov

This lack of FDA approval and the safety concerns raised by the agency mean that individuals who are considering using Selank should exercise caution. It is important to speak with a qualified healthcare provider before using any unapproved drug, including Selank. For more information on testosterone replacement therapy, another treatment option, visit our /testosterone-library.

Selank vs. Other Anxiety Treatments

For a more detailed comparison of different treatment options, you can use our /compare tool.

Conclusion

Selank is a promising peptide with potential anxiolytic effects. However, it is important to remember that it is not approved by the FDA and its long-term safety is unknown. Individuals who are considering using Selank should speak with a qualified healthcare provider to discuss the potential risks and benefits. Our /peptide-therapy-guide can provide more general information on this topic.

The specialists at TeleGenix can help you explore your options for managing anxiety and determine if peptide therapy is a suitable choice for you.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment.

References

1. Zozulia AA, Neznamov GG, Siuniakov TS, et al. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety and neurasthenic disorders]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48. PMID: 18454096
2. Kasian A, Shadrina M, Kolik L, et al. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behav Neurol. 2017;2017:5091027. PMID: 28280289
3. U.S. Food and Drug Administration. (2023). Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. FDA.gov